Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Appointments

Executives On The Move: New Hires at Omeros and Theratechnologies Plus Promotions at Alimera and Constellation

Omeros gains a new head of commercial and a VP of CMC from Celgene, while Alimera Sciences promotes its president to CEO and Constellation Pharma moves its translational sciences head to CSO.


Appointments BioPharmaceutical

Gilead Lures Roche Pharma CEO O'Day As CEO; Genentech's CEO Will Replace Him

O'Day brings Gilead experience in oncology and M&A from a large, diversified organization.

Appointments Leadership

Revolving Door: Novartis India Managing Director Quits

Novartis India’s managing director has quit - the second time in 2018 that the Swiss multinational finds the corner office vacated.

Commercial Appointments

Executives On The Move: Bayer Adds Two New VPs and Science Leader at Janssen R&D Leaves for New Opportunity

Bayer adds new VPs in Government Relations and US Corporate Engagement from Monsanto. And at Janssen R&D, Global Head, Discovery Sciences moves to CSO position at Incyte Corp. Meanwhile, Axovant Sciences revamps its team. 

Appointments BioPharmaceutical

Pharma CEO Pay Up In India, Ratio Versus Employee Earnings Glaring

Pharma CEOs in India took home higher remuneration in 2017-18, with experts suggesting that the upward trend isn’t entirely unexpected. The huge CEO-to-employee pay ratios – over 600 in one case – isn’t a healthy trend, though.
Commercial Strategy

Executives On The Move: New CSOs at Alize and Innovio, Plus Oncology Head at Nektar Therapeutics

Ipsen VP, Endocrinology is now CSO at metabolic and rare disease Alize Pharma, and cancer and infectious disease firm Innovio Pharmaceuticals promotes R&D leader to CSO. Plus new Head, Oncology at Nektar Therapeutics to lead area strategy.

Appointments BioPharmaceutical

Executives On The Move: Five Prime Fills Its CFO Slot, Myovant Appoints Chief Commercial Officer and Onconova Adds a CMO, R&D

Immuno-oncology treatment developer Five Prime Therapeutics hires a CFO, while Myovant Sciences, focused on women’s health and endocrine disease, appoints a chief commercial officer. And Onconova Therapeutics boosts its drug development expertise with addition of new CMO, R&D.

Appointments BioPharmaceutical

Executives On The Move: Comings And Goings This Week At Sosei And Shire, Plus An Upcoming Departure At Ferring

Sosei Group selects a new EVP, CFO and Rare Diseases VP departs Shire for Blueprint Medicines. At Ferring Pharmaceuticals, COO makes known plans to step down.

Appointments BioPharmaceutical

Ferring's New Chief Falk Talks

Ferring announced this morning (Oct. 31) that Michel Pettigrew is retiring as president of the executive board and will be succeeded by CSO Per Falk. The two spoke to Scrip recently and outlined the Swiss-based firm's future strategy.

Leadership Gynecology & Urology

Executives On The Move: Celgene Picks a Clinical Development Head And Axcella Health Gains a New CBO From Novartis

At NuVasive, a new CEO is slated to take charge. Celgene chooses as President, Global Clinical Development an exec from EMD Serono and Axcella Health fills its CBO slot with an oncology strategy leader from Novartis Pharma.
Appointments BioPharmaceutical

Executives On The Move: Merck & Co. Lands New Talent in Info Tech and at AstraZeneca a Global VP Will Make Tracks to Novo Nordisk

Merck & Co. Inc. is bringing aboard a new  information tech and digital strategy head from Nike. AstraZeneca's cardiovascular chief will head to Novo Nordisk as EVP, Biopharm early next year, and directors are added to the boards of Variant Pharma, Clinical Genomics and Bone Solutions.
Appointments BioPharmaceutical

Executives On The Move: New CEOs At Perrigo And SanBio, CMOs At CardioVascular BioTherapeutics And Harpoon Therapeutics, And A Retirement At BTG

This week's company moves include a new CEO for Perrigo, while Harpoon Therapeutics and CardioVascular BioTherapeutics get new chief medical officers. And after seven years, the the chairman of BTG shares his decision to depart at end of year.

Appointments BioPharmaceutical
See All